Agilent Technologies (NYSE:A) has been under a strong bear grip, hence the stock is down -1.33% when compared to the S&P 500 in the past 4 weeks. However, in the near-term, buying emerged at lower levels and the stock has outperformed the S&P 500 by 0.68% in the past 1 week. The stock has continued its bullish performance both in the near-term and the medium-term, as the stock is up 1.97% in the last 1 week, and is up 0.26% in the past 4 weeks. Buying continues as the stock moves higher, suggesting a strong appetite for the stock.
The company shares have rallied 13.81% from its 1 Year high price. On Jun 23, 2016, the shares registered one year high at $46.68 and the one year low was seen on Oct 2, 2015. The 50-Day Moving Average price is $45.14 and the 200 Day Moving Average price is recorded at $40.87.
The stock has recorded a 20-day Moving Average of 1.63% and the 50-Day Moving Average is 3.32%.
Agilent Technologies (NYSE:A): stock turned positive on Friday. Though the stock opened at $44.86, the bulls momentum made the stock top out at $45.55 level for the day. The stock recorded a low of $44.86 and closed the trading day at $45.48, in the green by 2.39%. The total traded volume for the day was 1,838,137. The stock had closed at $44.42 in the previous days trading.
In an insider trading activity, The Securities and Exchange Commission has divulged that Cullen James, director of Agilent Technologies Inc, had unloaded 16,697 shares at an average price of $45.78 in a transaction dated on May 27, 2016. The total value of the transaction was worth $764,389.
Agilent Technologies Inc. is engaged in the life sciences, diagnostics and applied chemical markets. The Company provides application focused solutions that include instruments, software, services and consumables for the entire laboratory workflow. The Company has three business segments: the life sciences and applied markets business, the diagnostics and genomics business, and the Agilent CrossLab business. The Companys life sciences and applied markets business segment brings together the Companys analytical laboratory instrumentation and informatics. The Companys diagnostics and genomics business segment consists of three businesses: the Dako business, the genomics business and the nucleic acid solutions business. The Companys Agilent CrossLab business segment combines its analytical laboratory services and consumables business.